Stryker shares plunge 8.8% after CFO reveals ongoing manufacturing issues.

Stryker Corporation's shares dropped 8.8% after CFO Preston Wells disclosed that a manufacturing problem in its Peripheral Vascular unit, previously thought resolved, is continuing into Q4 2026. This revelation wiped out over $10 billion in market value and sparked an investigation by Hagens Berman into whether Stryker fully disclosed the issue to investors. The ongoing supply disruptions have impacted sales and new business opportunities, raising concerns about the company's transparency and future performance.

Stryker Corporation's shares are down 0.81% on Pluang, trading at USD 273.26 as of Oct 02, 2026 01:31 WIB. The stock's market cap stands at $105.63 billion, with all current Pluang orders on the buy side.